Authors:
Hagedorn, HG
Sauer, U
Schleicher, ED
Nerlich, AG
Citation: Hg. Hagedorn et al., Divergence in distribution and prognostic significance of major basement components in laryngeal carcinomas, INT J ONCOL, 18(5), 2001, pp. 1045-1051
Authors:
Beck, A
Deeg, M
Moeschel, K
Schmidt, EK
Schleicher, ED
Voelter, WG
Haring, HU
Lehmann, R
Citation: A. Beck et al., Alkaline liquid chromatography/electrospray ionization skimmer collision-induced dissociation mass spectrometry for phosphopeptide screening, RAP C MASS, 15(23), 2001, pp. 2324-2333
Authors:
Ceol, M
Forino, M
Gambaro, G
Sauer, U
Schleicher, ED
D'Angelo, A
Anglani, F
Citation: M. Ceol et al., Quantitation of TGF-beta 1 mRNA in porcine mesangial cells by comparative kinetic RT/PCR: Comparison with ribonuclease protection assay and in situ hybridization, J CL LAB AN, 15(4), 2001, pp. 215-222
Authors:
Gambaro, G
Weigert, C
Ceol, M
Schleicher, ED
Citation: G. Gambaro et al., Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis, CONTR NEPHR, 131, 2001, pp. 107-113
Authors:
Weigert, C
Brodbeck, K
Haring, HU
Gambaro, G
Schleicher, ED
Citation: C. Weigert et al., Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation, KIDNEY INT, 60(3), 2001, pp. 935-943
Authors:
Weigert, C
Brodbeck, K
Lehmann, R
Haring, HU
Schleicher, ED
Citation: C. Weigert et al., Overexpression of glutamine : fructose-6-phosphate-amidotransferase induces transforming growth factor-beta 1 synthesis in NIH-3T3 fibroblasts, FEBS LETTER, 488(1-2), 2001, pp. 95-99
Authors:
Ceol, M
Gambaro, G
Sauer, U
Baggio, B
Anglani, F
Forino, M
Facchin, S
Bordin, L
Weigert, C
Nerlich, A
Schleicher, ED
Citation: M. Ceol et al., Glycosaminoglycan therapy prevents TGF-beta 1 overexpression and pathologic changes in renal tissue of long-term diabetic rats, J AM S NEPH, 11(12), 2000, pp. 2324-2336
Authors:
Weigert, C
Sauer, U
Brodbeck, K
Pfeiffer, A
Haring, HU
Schleicher, ED
Citation: C. Weigert et al., AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta 1 promoter in mesangial cells, J AM S NEPH, 11(11), 2000, pp. 2007-2016
Authors:
Lehmann, R
Huber, M
Beck, A
Schindera, T
Rinkler, T
Houdall, B
Weigert, C
Haring, HU
Voelter, W
Schleicher, ED
Citation: R. Lehmann et al., Simultaneous, quantitative analysis of UDP-N-acetylglucosamine, UDP-N-acetylgalactosamine, UDP-glucose and UDP-galactose in human peripheral blood cells, muscle biopsies and cultured mesangial cells by capillary zone electrophoresis, ELECTROPHOR, 21(14), 2000, pp. 3010-3015
Authors:
Beck, A
Lehmann, R
Gambaro, G
Haring, HU
Schleicher, ED
Voelter, W
Ceol, M
Citation: A. Beck et al., Advances in reverse transcription polymerase chain reaction analysis of cellular mRNA levels of transforming growth factor-beta 1 by capillary electrophoresis with laser-induced fluorescence detection, CLIN CH L M, 37(5), 1999, pp. 527-532
Citation: Ag. Nerlich et Ed. Schleicher, N-epsilon-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress, ATHEROSCLER, 144(1), 1999, pp. 41-47
Authors:
Hammes, HP
Alt, A
Niwa, T
Clausen, JT
Bretzel, RG
Brownlee, M
Schleicher, ED
Citation: Hp. Hammes et al., Differential accumulation of advanced glycation end products in the courseof diabetic retinopathy, DIABETOLOG, 42(6), 1999, pp. 728-736
Authors:
Nerlich, AG
Lebeau, A
Hagedorn, HG
Sauer, U
Schleicher, ED
Citation: Ag. Nerlich et al., Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx, ANTICANC R, 18(5A), 1998, pp. 3515-3520